Vinod Paul
Overview
Explore the profile of Vinod Paul including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
588
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Abed H, Radha R, Anjum S, Paul V, AlSawaftah N, Pitt W, et al.
Adv Healthc Mater
. 2024 Aug;
13(29):e2400833.
PMID: 39101627
Targeted cancer therapy (TCT) is gaining increased interest because it reduces the risks of adverse side effects by specifically treating tumor cells. TCT testing has traditionally been performed using two-dimensional...
2.
Fatima S, Sabouni R, Husseini G, Paul V, Gomaa H, Radha R
Nanomaterials (Basel)
. 2024 Jul;
14(13).
PMID: 38998686
Metal-organic frameworks (MOFs) are excellent candidates for a range of applications because of their numerous advantages, such as high surface area, porosity, and thermal and chemical stability. In this study,...
3.
Percival K, Paul V, Husseini G
Int J Mol Sci
. 2024 Jun;
25(11).
PMID: 38892199
In exploring the challenges of bone repair and regeneration, this review evaluates the potential of bone tissue engineering (BTE) as a viable alternative to traditional methods, such as autografts and...
4.
Radha R, Paul V, Anjum S, Bouakaz A, Pitt W, Husseini G
Sci Rep
. 2024 May;
14(1):10499.
PMID: 38714740
Improving the efficacy of chemotherapy remains a key challenge in cancer treatment, considering the low bioavailability, high cytotoxicity, and undesirable side effects of some clinical drugs. Targeted delivery and sustained...
5.
Agam M, Paul V, Abdelgawad M, Husseini G
IEEE Trans Nanobioscience
. 2024 Mar;
23(3):472-481.
PMID: 38530728
Liposomes are spherical vesicles formed from bilayer lipid membranes that are extensively used in targeted drug delivery as nanocarriers to deliver therapeutic reagents to specific tissues and organs in the...
6.
Awad N, Paul V, AlSawaftah N, Husseini G
Sci Rep
. 2023 Oct;
13(1):16644.
PMID: 37789072
Liposomes are the most successful nanoparticles used to date to load and deliver chemotherapeutic agents to cancer cells. They are nano-sized vesicles made up of phospholipids, and targeting moieties can...
7.
Karami A, Ahmed A, Sabouni R, Husseini G, Sharabati M, AlSawaftah N, et al.
Colloids Surf B Biointerfaces
. 2022 Jun;
217:112599.
PMID: 35714509
In this work, liposome-coated iron (III) benzene-1,3,5-tricarboxylate (Fe-BTC) metal-organic framework is examined as a promising pH/Ultrasound dual-responsive nanocarriers for doxorubicin (DOX) delivery. The successful coating of the MOF particles (Lip-Fe-BTC)...
8.
AlSawaftah N, Paul V, Kosaji D, Khabbaz L, Awad N, Husseini G
Artif Cells Nanomed Biotechnol
. 2022 May;
50(1):111-120.
PMID: 35543613
Targeted liposomes enable the delivery of encapsulated chemotherapeutics to tumours by targeting specific receptors overexpressed on the surfaces of cancer cells; this helps in reducing the systemic side effects associated...
9.
Krishnakumar S, Paul V, Ariyath A, Anoop P, Sreekumar S, Menon D, et al.
ACS Appl Bio Mater
. 2022 Jan;
2(5):2294.
PMID: 35030695
No abstract available.
10.
Krishnakumar S, Paul V, Ariyath A, Anoop P, Sreekumar S, Menon D, et al.
ACS Appl Bio Mater
. 2022 Jan;
2(2):737-746.
PMID: 35016278
Graphene quantum dots (GQDs) have emerged as promising biolabeling agents owing to their stable innate fluorescence, photostability, and biocompatibility as opposed to semiconductor quantum dots. While several studies reported GQDs...